4577 Stock Overview
Manufactures and sells pharmaceutical products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Daito Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,025.00 |
| 52 Week High | JP¥2,573.00 |
| 52 Week Low | JP¥1,803.00 |
| Beta | 0.27 |
| 1 Month Change | -3.43% |
| 3 Month Change | -10.87% |
| 1 Year Change | 12.06% |
| 3 Year Change | -23.72% |
| 5 Year Change | -30.17% |
| Change since IPO | 63.35% |
Recent News & Updates
Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture
Jul 19
Shareholder Returns
| 4577 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -2.6% | -1.2% | -0.9% |
| 1Y | 12.1% | 9.8% | 13.7% |
Return vs Industry: 4577 exceeded the JP Pharmaceuticals industry which returned 9.8% over the past year.
Return vs Market: 4577 underperformed the JP Market which returned 13.7% over the past year.
Price Volatility
| 4577 volatility | |
|---|---|
| 4577 Average Weekly Movement | 2.7% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.4% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4577 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4577's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1942 | 1,070 | Hiroshi Matsumori | www.daitonet.co.jp |
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. It offers generic drugs, active pharmaceutical ingredients, and over the counter drugs; and contract manufacturing services for formulations products, high-potent drugs, and packaging.
Daito Pharmaceutical Co.,Ltd. Fundamentals Summary
| 4577 fundamental statistics | |
|---|---|
| Market cap | JP¥30.74b |
| Earnings (TTM) | JP¥3.23b |
| Revenue (TTM) | JP¥47.40b |
9.6x
P/E Ratio0.7x
P/S RatioIs 4577 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4577 income statement (TTM) | |
|---|---|
| Revenue | JP¥47.40b |
| Cost of Revenue | JP¥37.78b |
| Gross Profit | JP¥9.61b |
| Other Expenses | JP¥6.38b |
| Earnings | JP¥3.23b |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
Jan 10, 2025
| Earnings per share (EPS) | 211.21 |
| Gross Margin | 20.28% |
| Net Profit Margin | 6.82% |
| Debt/Equity Ratio | 23.3% |
How did 4577 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield30%
Payout RatioDoes 4577 pay a reliable dividends?
See 4577 dividend history and benchmarks| Daito PharmaceuticalLtd dividend dates | |
|---|---|
| Ex Dividend Date | Nov 28 2024 |
| Dividend Pay Date | Feb 03 2025 |
| Days until Ex dividend | 22 days |
| Days until Dividend pay date | 45 days |
Does 4577 pay a reliable dividends?
See 4577 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 14:52 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2024/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Daito Pharmaceutical Co.,Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Masao Yoshida | Ichiyoshi Research Institute Inc. |
| Yukichi Okabe | Okasan Securities Co. Ltd. |
| Takashi Akahane | Tokai Tokyo Intelligence Laboratory Co., Ltd. |